B29D11/00096

SYSTEMS AND METHODS FOR PRINTING ON A CONTACT LENS
20240248327 · 2024-07-25 ·

One embodiment of a contact lens includes a lens body configured to fit directly on the surface of the eye and legible characters positioned on the lens body. Another embodiment of a contact lens comprises a lens body including polymeric material and a lens enhancing material (e.g., ink, silicone material, medicament material, and the like) encapsulated in the polymeric material. The lens enhancing material can be in the form of isolated sections distributed in the surrounding polymeric material. Methods of making contact lenses include forming a first lens layer including a first surface, forming a pattern on the first surface, and forming a second lens layer over the pattern.

INTRAOCULAR LENS COMPRISING DRUG-CONTAINING MICROSPHERES

An intraocular lenses having a plurality of drug-containing microspheres attached to the intraocular lens. The intraocular lenses can be used for patients undergoing cataract surgery and reduces the need for recurrent surgery, follow-up treatment or postoperative eye-drops. Also provides a method for manufacturing such an intraocular lens and the use of an intraocular lens in the treatment of cataract.

NON-INVASIVE OCULAR DRUG DELIVERY INSERT TECHNOLOGY

Non-invasive Ocular Drug Delivery Insert Technology. The invention concerns an ocular insert which is a new biocompatible polymer-based controlled drug delivery system (CDDS) applicable to a variety of drugs and other compounds for the treatment of different ocular pathologies. This ocular insert allows releasing of at least one drug under suitable concentration levels during suitable periods of time. The device may be inserted in the lower or upper fornix conjunctiva, in a non-invasive way, meaning that the patient will be able to place the device himself, without intervention of medical specialized staff. The insert of the invention will release the drug in such a controlled rate that will allow the drug release up to 300 days by either a Fickian or a linear profile according to the intend purpose or pathology. The insert can be prepared with different shapes (spherical or spherical dome) and/or architectures (monolithic/layered either with or without a drug core) allowing the incorporation of at least one drug which can be released at different rates. The size, shape and design of the insert is adjusted in order to tune the drug(s) delivery profile(s) and to inhibit the risk of displacement or expulsion.

CONTACT LENS WITH SURFACE MODIFICATION AND THE METHOD FOR ITS PREPARATION
20190009482 · 2019-01-10 ·

A surface-modified contact lens, having a surface contact angle hysteresis of less than 15?, includes a lens body and a first surface modification layer disposed on a surface of the lens body. The first surface modification layer comprises a first reactive hydrophilic polymer. The surface of the lens body has a first functional group or a second functional group, and the first reactive hydrophilic polymer has a third functional group or a fourth functional group. A first covalent cross-link bond is formed between the surface of the lens body and the first surface modification layer. The first covalent cross-link bond is formed by reacting the first functional group or the second functional group of the surface of the lens body with the third functional group or the fourth functional group of the first reactive hydrophilic polymer.

Esculentin 1a Derivatives and Uses Thereof

Provided herein are synthetic antibacterial peptides that have a sequence at least 80% identical to a sequence shown in SEQ ID NO: 2 or the diastereomer thereof with a sequence shown in SEQ ID NO: 3 or pharmaceutical compositions thereof. Also provided are methods for stimulating wound healing via the synthetic antibacterial peptides and for forming an antimicrobial coating on contact lenses. In addition a device is provided that has a surface with a coating of the synthetic antibacterial peptides.

CONTACT LENS

A contact lens having an amount of at least one cooling agent and at least one TRPV1 inhibitor releasably adhered is described as well as method of manufacturing the same. The contact lens can be comfortably worn by contact lens wearers and can increase the duration of comfortable lens wearing time and/or reduce lens awareness events and/or reduce contact lens dryness in a symptomatic contact lens wearer and further can reduce or avoid any stinging/burning sensation when the contact lens is first used or a short time thereafter.

METHOD TO MANUFACTURE A MOLD FOR LENSES, AND CORRESPONDING MOLD
20240300198 · 2024-09-12 ·

The invention concerns a method to manufacture a mold (10) for forming contact lenses (100) using the technique of molding with molds of monomeric and/or polymeric material; such molds (10) comprise a male element (11) and a female element (12), which cooperate to define a cavity suitable to accommodate monomeric and/or polymeric material in the liquid state intended to form the lens (100), wherein the method provides to obtain, by means of laser processing, a plurality of grooves (23) in the male element (11) intended to form functional elements in relief (101) of the lenses (100). The invention also concerns a mold (10) for contact lenses (100) made of monomeric and/or polymeric material that can be obtained with the method as above.

CONTACT LENS FOR COLLECTING TEAR OR DELIVERING DRUG, AND METHOD FOR MANUFACTURING THE CONTACT LENS

A contact lens for collecting tear or delivering a drug includes an inner lens placed on an eyeball, an outer lens provided at an outer side of the inner lens to overlap the inner lens, and a plurality of pillars disposed between the inner lens and the outer lens to form a space between the inner lens and the outer lens, wherein the contact lens has a plurality of interfacing ports for connecting a chamber with an outside.

Extended release drug-delivery contact lenses and methods of making

Contact lenses are described that include particles of polymer fiber mat incorporated into a polymer lens wherein the polymer fiber mat is formed by electrospinning a prepolymer solution. Methods for making the contact lenses with improved oxygen permeability are also described. Methods for making the contact lens with optional therapeutic drug delivery and refractive correction are also described.

Contact lens

A contact lens having an amount of at least one cooling agent and at least one TRPV1 inhibitor releasably adhered is described as well as method of manufacturing the same. The contact lens can be comfortably worn by contact lens wearers and can increase the duration of comfortable lens wearing time and/or reduce lens awareness events and/or reduce contact lens dryness in a symptomatic contact lens wearer and further can reduce or avoid any stinging/burning sensation when the contact lens is first used or a short time thereafter.